Liquid Biopsies – News and Features

This article will focus on some of the advances currently being made in the field of liquid biopsy, from attempts to improve the sensitivity of tests, to using bodily fluids other than blood.

Researchers have developed a urine-based test that can detect DNA fragments released by head and neck cancers, potentially facilitating early diagnosis.

Scientists have developed a coin-sized chip that can directly isolate blood plasma from a tube of blood in just 30 minutes, which is more convenient and user-friendly as compared to the current gold standard, multi-step centrifugation process.

Researchers from the Johns Hopkins Kimmel Cancer Center have developed a machine-learning approach that identifies these sequences in both tumor DNA and cell-free DNA (cfDNA) that are shed into the blood.

A blood test that screens for circulating tumor DNA in people with an average risk for colorectal cancer is 83% accurate at detecting the disease, reports a new study.

Explore how innovations in the cancer diagnostic space, particularly those focusing on simple but effective diagnostic methodologies, could make cancer screening and early detection more straightforward, improving access and outcomes for patients.

We typically think of a cancerous tumor as a bunch of abnormal cells gone rogue, but the situation is more complicated. This article will explore cell-to-cell communication’s role in cancer development, its influence on metastasis and how research is expanding our knowledge of the disease.

Blood test uses cell-free DNA methylation to quantify tumor burden and distinguish neuroendocrine prostate cancer from prostate adenocarcinoma.

A vaccine has shown the potential to prevent the relapse of KRAS-mutated pancreatic and colorectal cancers in a phase I trial.

Progress in the search for biomarkers to help predict, manage and assess treatment of acute kidney injury has been reported by researchers.